Jeena Sikho Lifecare to Host Q1 FY2025-26 Earnings Conference Call on August 18
Jeena Sikho Lifecare Limited (JSLL) will host a conference call on August 18, 2025, at 4:00 PM IST to discuss Q1 FY2025-26 operational and financial performance. Managing Director Manish Grover and CFO Nanak Chand will lead the call. Dial-in numbers for various countries are provided. JSLL recently reported Q1 revenue of Rs. 17,428.59 lakhs and profit after tax of Rs. 5,131.14 lakhs. The company, which migrated to the Main Board of BSE/NSE on August 11, 2025, operates in Ayurvedic medicines and therapies.
*this image is generated using AI for illustrative purposes only.
Jeena Sikho Lifecare Limited (JSLL), a leading Ayurvedic healthcare company, has announced it will host a conference call for investors and analysts to discuss its operational and financial performance for the first quarter of fiscal year 2025-26. The call is scheduled for Monday, August 18, 2025, at 4:00 PM IST.
Key Participants
The company's management team will be represented by:
- Mr. Manish Grover, Managing Director
- Mr. Nanak Chand, Chief Financial Officer
This conference call will provide an opportunity for investors and analysts to gain insights into JSLL's performance and future outlook directly from the company's leadership.
Dial-in Information
Interested parties can access the call through the following dial-in numbers:
| Country | Dial-in Number |
|---|---|
| India | +91 22 6280 1326 or +91 22 7115 8227 |
| USA | 1-866-746-2133 |
| UK | 0808-101-1573 |
| Singapore | 800-101-2045 |
| Hong Kong | 800-964-448 |
Participants are required to register in advance for the call through a provided link.
Recent Financial Performance
This earnings call follows JSLL's recent announcement of its unaudited quarterly financial results for the quarter ended June 30, 2025. The company reported:
- Revenue from operations: Rs. 17,428.59 lakhs
- Profit after tax: Rs. 5,131.14 lakhs (standalone results)
The upcoming conference call will likely delve deeper into these financial results, discussing key performance indicators, growth strategies, and addressing questions from the investment community.
Company Background
Jeena Sikho Lifecare Limited, which recently migrated to the Main Board of BSE/NSE on August 11, 2025, has been making strides in the Ayurvedic healthcare sector. The company operates in the business of trading Ayurvedic medicines and providing Ayurvedic therapies.
Participation Information
Investors and analysts interested in participating in the call are advised to register in advance and prepare their questions for the management team.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research and consult with financial advisors before making any investment decisions.
16
